Ledger.Open graph →
SEC Form D · filed December 31, 2024

Cyrus Biotechnology, Inc

Offering
$3.5M
Sold
$3.2M
Exemption
Rule 506(b)
Industry
Other Technology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

G. S. Greenburg · Seattle, WAExec · DirectorDavid N. Oakley · BIRMINGHAM, ALDirectorTurk C. Stovall · Old Bethpage, NYDirectorSteve M. Jones · DALLAS, TXDirectornull InvestX Master GP1 Inc · New York, NYExec · DirectorSSM Growth Equity Management IV, LLC · Memphis, TNExecSumita Pennathur · Goleta, CADirectorAdam Manager V, LLC · Omaha, NEDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗